title: Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
abstract: The aim of this study was to identify cell populations relevant to pathogenesis and repair within the injured CNS in mice that recovered from experimental autoimmune encephalomyelitis (EAE). We demonstrate that in two EAE models, with either relapsing-remitting or chronic course, T-cells and resident activated microglia manifested extensive IL-17 expression, with apparent localization within regions of myelin loss. In mice treated with glatiramer acetate (GA, Copaxone), even when treatment started after disease exacerbation, CNS inflammation and Th-17 occurrence were drastically reduced, with parallel elevation in T-regulatory cells, indicating the immunomodulatory therapeutic consequences of GA treatment in situ.
authors.affiliation: The Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
authors.forename: Rina
authors.initials: R
authors.lastname: Aharoni
authors.forename: Raya
authors.initials: R
authors.lastname: Eilam
authors.forename: Ariel
authors.initials: A
authors.lastname: Stock
authors.forename: Anya
authors.initials: A
authors.lastname: Vainshtein
authors.forename: Elias
authors.initials: E
authors.lastname: Shezen
authors.forename: Hilah
authors.initials: H
authors.lastname: Gal
authors.forename: Nir
authors.initials: N
authors.lastname: Friedman
authors.forename: Ruth
authors.initials: R
authors.lastname: Arnon
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000187:drug effects / Q000473:pathology; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D000068717:Glatiramer Acetate; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000276:immunology; D020381:Interleukin-17 / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D018991:Myelin Proteolipid Protein / Q000276:immunology; D010446:Peptide Fragments / Q000276:immunology; D010455:Peptides / Q000627:therapeutic use*; D013116:Spinal Cord / Q000473:pathology; D013223:Statistics as Topic; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects*
chemical_list: D007166:Immunosuppressive Agents; D020381:Interleukin-17; D018991:Myelin Proteolipid Protein; D010446:Peptide Fragments; D010455:Peptides; C435023:myelin proteolipid protein (139-151); D000068717:Glatiramer Acetate